We have a modern epidemic of neurodevelopmental issues in our children
No, increased sweating or hyperhidrosis is not listed as a recognized adverse effect in the FDA-approved prescribing information for Zepbound (tirzepatide)
The recent rise in GLP-1 prescriptions has drawn more attention to tools that give clinicians and patients better visibility into daily glucose patterns
Picolinato de Cromo contribuye a un metabolismo saludable de los carbohidratos
These modifications may include the Vssc mutation, insensitivity of synaptic acetylcholinesterase (AChE1) and mutation in the GABA receptor [56]
Use of SAXENDA for this indication is supported by a 56-week double-blind, placebo-controlled clinical trial in 251 pediatric patients aged 12 to 17 years, a pharmacokinetic study in pediatric patients, and studies in adults with obesity [see Clinical Pharmacology (12.3), Clinical Studies (14.1, 14.2)]